Literature DB >> 33189181

The overlap between irritable bowel syndrome and organic gastrointestinal diseases.

Imran Aziz1, Magnus Simrén2.   

Abstract

Irritable bowel syndrome (IBS) is a common functional bowel disorder characterised by symptoms of recurrent abdominal pain associated with a change in bowel habit. This condition is one of the most frequent reasons to seek a gastroenterology consultation in primary and secondary care. The diagnosis of IBS is made by identifying characteristic symptoms, as defined by the Rome criteria, and excluding organic gastrointestinal diseases that might otherwise explain these symptoms. Organic conditions that can be mistaken for IBS include coeliac disease, inflammatory bowel disease (IBD), colorectal cancer, and, in those with diarrhoea-predominant symptoms, chronic gastrointestinal infections, microscopic colitis, and primary bile acid diarrhoea. The concept of small intestinal bacterial overgrowth being associated with IBS is shrouded with controversy and uncertainty, mainly because of invalid tests due to poor sensitivity and specificity, potentially leading to incorrect assumptions. There is insufficient evidence to link IBS-type symptoms with exocrine pancreatic insufficiency or with symptomatic uncomplicated diverticular disease, since both are hampered by conflicting data. Finally, there is growing appreciation that IBS can present in patients with known but stable organic gastrointestinal diseases, such as quiescent IBD or coeliac disease. Recognising functional gut symptoms in these individuals is paramount so that potentially harmful escalations in immunosuppressive therapy can be avoided and attention can be focused on addressing disorders of gut-brain interaction. This Review endeavours to aid clinicians who practise adult gastroenterology in recognising the potential overlap between IBS and organic gastrointestinal diseases and highlights areas in need of further research and clarity.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 33189181     DOI: 10.1016/S2468-1253(20)30212-0

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


  12 in total

1.  Functional Abdominal Cramping Pain: Expert Practical Guidance.

Authors:  Stefan Müller-Lissner; Viola Andresen; Maura Corsetti; Luis Bustos Fernández; Sylvie Forestier; Fabio Pace; Miguel A Valdovinos
Journal:  J Clin Gastroenterol       Date:  2022-09-23       Impact factor: 3.174

2.  Moxibustion for diarrhea in COVID-19: A protocol for systematic review and meta-analysis.

Authors:  Ningning Liu; Yingxue Xu; Dongbin Zhang; Lianzhu Wang; Yi Hou; Jiafu Ji
Journal:  Medicine (Baltimore)       Date:  2022-02-11       Impact factor: 1.817

3.  Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis.

Authors:  Angelo Viscido; Marco Valvano; Gianpiero Stefanelli; Annalisa Capannolo; Chiara Castellini; Eugenia Onori; Antonio Ciccone; Filippo Vernia; Giovanni Latella
Journal:  BMC Gastroenterol       Date:  2022-03-03       Impact factor: 3.067

4.  Public Awareness of Bowel Cancer Risk Factors, Symptoms and Screening in Tasmania, Australia: A Cross-Sectional Study.

Authors:  Simone M Lee; Vincent L Versace; Kehinde Obamiro
Journal:  Int J Environ Res Public Health       Date:  2022-01-28       Impact factor: 3.390

5.  Overlap between irritable bowel syndrome and common gastrointestinal diagnoses: a retrospective cohort study of 29,553 outpatients in Germany.

Authors:  Sven H Loosen; Karel Kostev; Tom Luedde; Christoph Roderburg; Markus S Jördens
Journal:  BMC Gastroenterol       Date:  2022-02-05       Impact factor: 3.067

Review 6.  Insights into the underlying mechanisms and clinical management of microscopic colitis in relation to other gastrointestinal disorders.

Authors:  Yuanbin Liu; Mingkai Chen
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-04-07

7.  Risk of Colorectal Cancer in Patients With Irritable Bowel Syndrome: A Meta-Analysis of Population-Based Observational Studies.

Authors:  Xinhui Wu; Jingxi Wang; Zhen Ye; Jin Wang; Xibei Liao; Mengsi Liv; Zhen Svn
Journal:  Front Med (Lausanne)       Date:  2022-03-02

8.  The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult.

Authors:  Hannah Ceuleers; Nikita Hanning; Michelle De Bruyn; Joris G De Man; Heiko U De Schepper; Qian Li; Liansheng Liu; Steven Abrams; Annemieke Smet; Jurgen Joossens; Koen Augustyns; Ingrid De Meester; Pankaj J Pasricha; Benedicte Y De Winter
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

9.  Unraveling the relationship between autoimmune pancreatitis type 2 and inflammatory bowel disease: Results from two centers and systematic review of the literature.

Authors:  Sara Nikolic; Marco Lanzillotta; Nikola Panic; Torkel B Brismar; Carlos Fernández Moro; Gabriele Capurso; Emanuel Della Torre; J-Matthias Löhr; Miroslav Vujasinovic
Journal:  United European Gastroenterol J       Date:  2022-05-08       Impact factor: 6.866

10.  Moxibustion for diarrhea-predominant irritable bowel syndrome: A protocol for systematic review and network meta-analysis.

Authors:  Tiantian Dong; Xuhao Li; Xin Ma; Xiqing Xue; Yi Hou; Yuanxiang Liu; Jiguo Yang
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.